Publications by authors named "B Fiol"

We propose an exact formula for the energy radiated by an accelerating quark in N=2 superconformal theories in four dimensions. This formula reproduces the known bremsstrahlung function for N=4 theories and provides a prediction for all the perturbative and instanton corrections in N=2 theories. We perform a perturbative check of our proposal up to three loops.

View Article and Find Full Text PDF

We use the AdS/CFT correspondence to compute the energy radiated by an infinitely massive half-Bogomol'nyi-Prasad-Sommerfeld particle charged under N=4 super Yang-Mills theory, transforming in the symmetric or antisymmetric representation of the gauge group, and moving in the vacuum, to all orders in 1/N and for large 't Hooft coupling. For the antisymmetric case we consider D5-branes reaching the boundary of five-dimensional anti-de Sitter space (AdS(5)) at arbitrary timelike trajectories, while for the symmetric case, we consider a D3-brane in AdS(5) that reaches the boundary at a hyperbola. We compare our results to the one obtained for the fundamental representation, deduced by considering a string in AdS(5).

View Article and Find Full Text PDF

We demonstrate that certain supersymmetric Gödel-like universe solutions of supergravity are not solutions of string theory. This is achieved by realizing that supertubes are Bogomol'nyi-Prasad-Sommerfeld states in these spaces, and under certain conditions, when wrapping closed timelike curves, some world-volume modes develop negative kinetic terms. Since these universes are homogeneous, this instability takes place everywhere in space-time.

View Article and Find Full Text PDF

Background: Hepatitis B surface antigenemia (HBsAg) has been considered at least a relative contraindication for heart transplantation, yet patients have undergone liver transplantation for hepatitis B-induced chronic liver disease, albeit with poorer results than for other liver diseases. The impact of asymptomatic hepatitis B infection on heart transplant outcome is not known.

Methods: To examine this question, we queried the Joint International Society for Heart and Lung Transplantation/United Network of Organ Sharing Thoracic Registry for all patients undergoing heart transplantation who had been identified as positive for HBsAg before transplantation.

View Article and Find Full Text PDF